Top
image: tashatuvango/Fotolia

Preventative HIV vaccines induce robust, comparable immune responses in humans and monkeys

July 9, 2018

More than three decades after the identification of the human immunodeficiency virus (HIV), scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year.

In a new study, published July 6 in The Lancet, a team of researchers led by Beth Israel Deaconess Medical Center’s Dan H. Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research in collaboration with Janssen Vaccines & Prevention and other partners, evaluated a series of preventative HIV vaccine regimens in uninfected human volunteers in five countries.

Read More on The Medical News